Board of Scientific Counselors, Office of Infectious Diseases (BSC, OID), 55888 [2018-24462]
Download as PDF
<![CDATA[
55888
Federal Register / Vol. 83, No. 217 / Thursday, November 8, 2018 / Notices
a draft NORA Agenda entitled National
Occupational Research Agenda for
Immune, Infectious and Dermal Disease
Prevention (IID) for public comment. To
view the notice and related materials,
visit https://www.regulations.gov and
enter CDC–2018–0103 in the search
field and click ‘‘Search.’’
Table of Contents
•
•
•
•
•
Dates
Addresses
For Further Information Contact
Supplementary Information
Background
Electronic or written comments
must be received by January 7, 2019.
ADDRESSES: You may submit comments,
identified by CDC–2018–0103 and
docket number NIOSH–322, by any of
the following methods:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: National Institute for
Occupational Safety and Health, NIOSH
Docket Office, 1090 Tusculum Avenue,
MS C–34, Cincinnati, Ohio 45226–1998.
Instructions: All submissions received
in response to this notice must include
the agency name and docket number
[CDC–2018–0103; NIOSH–322]. All
relevant comments received will be
posted without change to https://
www.regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
https://www.regulations.gov. All
information received in response to this
notice will also be available for public
examination and copying at the NIOSH
Docket Office, 1150 Tusculum Avenue,
Room 155, Cincinnati, OH 45226–1998.
FOR FURTHER INFORMATION CONTACT:
Emily Novicki (NORACoordinator@
cdc.gov), National Institute for
Occupational Safety and Health, Centers
for Disease Control and Prevention,
Mailstop E–20, 1600 Clifton Road NE,
Atlanta, GA 30329, phone (404) 498–
2581 (not a toll free number).
SUPPLEMENTARY INFORMATION: The
National Occupational Research Agenda
(NORA) is a partnership program
created to stimulate innovative research
and improved workplace practices. The
national agenda is developed and
implemented through the NORA sector
and cross-sector councils. Each council
develops and maintains an agenda for
its sector or cross-sector.
Background: The National
Occupational Research Agenda for
Immune, Infectious and Dermal Disease
Prevention (IID) is intended to identify
the research, information, and actions
most urgently needed to prevent
daltland on DSKBBV9HB2PROD with NOTICES
DATES:
VerDate Sep<11>2014
16:51 Nov 07, 2018
Jkt 247001
occupational disease. The document
provides a vehicle for stakeholders to
describe the most relevant issues, gaps,
and safety and health needs for the
sector. Each NORA research agenda is
meant to guide or promote high priority
research efforts on a national level,
conducted by various entities,
including: Government, higher
education, and the private sector. This
is the first IID Agenda, developed for the
third decade of NORA (2016–2026). The
agenda was developed considering
information about injuries, the state of
the science, and the probability that
new information and approaches will
make a difference. As the steward of the
NORA process, NIOSH invites
comments on the draft National
Occupational Research Agenda for
Immune, Infectious and Dermal Disease
Prevention (IID). Comments expressing
support or with specific
recommendations to improve the
Agenda are requested. A copy of the
draft Agenda is available at https://
www.regulations.gov (see Docket
Number CDC–2018–0103).
Frank J. Hearl,
Chief of Staff, National Institute for
Occupational Safety and Health, Centers for
Disease Control and Prevention.
[FR Doc. 2018–24443 Filed 11–7–18; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors, Office
of Infectious Diseases (BSC, OID)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Board of Scientific Counselors,
Office of Infectious Diseases (BSC, OID).
This meeting is open to the public,
limited only by the space available; the
meeting room will accommodate up to
100 people. The public is also welcome
to listen to the meeting by telephone,
limited only by the number of ports
available (50); the toll-free dial-in
number is 1–877–951–7311, with a pass
code of 4123441.
DATES: The meeting will be held on
December 5, 2018, 8:30 a.m. to 5 p.m.,
EST, and December 6, 2018, 8:30 a.m. to
12 p.m., EST.
SUMMARY:
PO 00000
Frm 00038
Fmt 4703
Sfmt 9990
CDC, Global
Communications Center, 1600 Clifton
Road NE, Building 19, Auditorium B3,
Atlanta, Georgia 30329–4027; also 1–
877–951–7311, with a pass code of
4123441.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Sarah Wiley, MPH, Designated Federal
Officer, CDC, 1600 Clifton Road NE,
Mailstop H24–12, Atlanta, Georgia
30329–4027, Telephone (404) 639–4840;
sed5@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The BSC, OID, provides
advice and guidance to the Secretary,
Department of Health and Human
Services; the Director, CDC; the OID,
CDC; and the Directors of the National
Center for Immunization and
Respiratory Diseases, the National
Center for Emerging and Zoonotic
Infectious Diseases, and the National
Center for HIV/AIDS, Viral Hepatitis,
STD, and TB Prevention, CDC, in the
following areas: Strategies, goals, and
priorities for programs; research within
the national centers; and overall
strategic direction and focus of OID and
the national centers.
Matters to be Considered: The agenda
will include updates from the infectious
disease national centers and the Center
for Global Health along with focused
discussions on recent outbreaks and
affected populations. Reports back from
two workgroups will also be given: (1)
The Board’s Food Safety Modernization
Act Surveillance Working Group and (2)
the Vector-borne Diseases Workgroup of
the BSC, OID, and the Board of
Scientific Counselors, National Center
for Environmental Health/Agency for
Toxic Substances and Disease Registry.
Agenda items are subject to change as
priorities dictate.
The Chief Operating Officer, Centers
for Disease Control and Prevention, has
been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2018–24462 Filed 11–7–18; 8:45 am]
BILLING CODE 4163–19–P
E:\FR\FM\08NON1.SGM
08NON1
]]>Agencies
[Federal Register Volume 83, Number 217 (Thursday, November 8, 2018)]
[Notices]
[Page 55888]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-24462]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, Office of Infectious Diseases
(BSC, OID)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Board of Scientific Counselors,
Office of Infectious Diseases (BSC, OID). This meeting is open to the
public, limited only by the space available; the meeting room will
accommodate up to 100 people. The public is also welcome to listen to
the meeting by telephone, limited only by the number of ports available
(50); the toll-free dial-in number is 1-877-951-7311, with a pass code
of 4123441.
DATES: The meeting will be held on December 5, 2018, 8:30 a.m. to 5
p.m., EST, and December 6, 2018, 8:30 a.m. to 12 p.m., EST.
ADDRESSES: CDC, Global Communications Center, 1600 Clifton Road NE,
Building 19, Auditorium B3, Atlanta, Georgia 30329-4027; also 1-877-
951-7311, with a pass code of 4123441.
FOR FURTHER INFORMATION CONTACT: Sarah Wiley, MPH, Designated Federal
Officer, CDC, 1600 Clifton Road NE, Mailstop H24-12, Atlanta, Georgia
30329-4027, Telephone (404) 639-4840; [email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The BSC, OID, provides advice and guidance to the
Secretary, Department of Health and Human Services; the Director, CDC;
the OID, CDC; and the Directors of the National Center for Immunization
and Respiratory Diseases, the National Center for Emerging and Zoonotic
Infectious Diseases, and the National Center for HIV/AIDS, Viral
Hepatitis, STD, and TB Prevention, CDC, in the following areas:
Strategies, goals, and priorities for programs; research within the
national centers; and overall strategic direction and focus of OID and
the national centers.
Matters to be Considered: The agenda will include updates from the
infectious disease national centers and the Center for Global Health
along with focused discussions on recent outbreaks and affected
populations. Reports back from two workgroups will also be given: (1)
The Board's Food Safety Modernization Act Surveillance Working Group
and (2) the Vector-borne Diseases Workgroup of the BSC, OID, and the
Board of Scientific Counselors, National Center for Environmental
Health/Agency for Toxic Substances and Disease Registry. Agenda items
are subject to change as priorities dictate.
The Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2018-24462 Filed 11-7-18; 8:45 am]
BILLING CODE 4163-19-P
